Patent details
EP3265122 Title: COMBINATION OF PEMBROLIZUMAB AND ERIBULIN FOR TREATING TRIPLE-NEGATIVE BREAST CANCER
Basic Information
- Publication number:
- EP3265122
- PCT Application Number:
- US2016020734
- Type:
- European Patent Granted for LU
- Legal Status:
- Revoked
- Application number:
- EP167108919
- PCT Publication Number:
- WO2016141209
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMBINATION OF PEMBROLIZUMAB AND ERIBULIN FOR TREATING TRIPLE-NEGATIVE BREAST CANCER
- French Title of Invention:
- COMBINAISON DE PEMBROLIZUMAB ET D'ÉRIBULINE DESTINÉE AU TRAITEMENT DU CANCER DU SEIN TRIPLE NÉGATIF
- German Title of Invention:
- KOMBINATION AUS PEMBROLIZUMAB UND ERIBULIN ZUR BEHANDLUNG VON TRIPLE-NEGATIVEM BRUSTKREBS
- SPC Number:
Dates
- Filing date:
- 03/03/2016
- Grant date:
- 04/05/2022
- EP Publication Date:
- 10/01/2018
- PCT Publication Date:
- 09/09/2016
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 04/05/2022
- EP B1 Publication Date:
- 04/05/2022
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 03/03/2036
- Renunciation date:
- Revocation date:
- 16/06/2023
- Annulment date:
Owner
- From:
- 27/04/2022
- Name:
- Eisai R&D Management Co., Ltd.
- Address:
- 6-10, Koishikawa 4-chome Bunkyo-ku, Tokyo 112-8088, Japan (JP)
- Name:
- Merck Sharp & Dohme Corp.
- Address:
- 126 East Lincoln Avenue, Rahway, NJ 07065, United States (US)
Inventor
1
- Name:
- AKTAN, Gursel
- Address:
- United States (US)
2
- Name:
- KARANTZA, Vassiliki
- Address:
- United States (US)
3
- Name:
- FUNAHASHI, Yasuhiro
- Address:
- Japan (JP)
4
- Name:
- MATSUI, Junji
- Address:
- Japan (JP)
5
- Name:
- BERRAK, Erhan
- Address:
- United States (US)
6
- Name:
- YUAN, RuiRong
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201562128373 P
- Priority Date:
- 04/03/2015
- Priority Country:
- United States (US)
2
- Priority Number:
- 201562264068 P
- Priority Date:
- 07/12/2015
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 39/395; A61K 45/06; A61K 47/26; A61K 31/357; A61P 35/00; A61P 35/04;
Publication
Bulletin
- Bulletin Heading:
- VRV
- Bulletin edition number:
- 2023/12
- Publication date:
- 06/11/2023
- Description:
- Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates
European Patent Bulletin
1
- Issue number:
- 202218
- Publication date:
- 04/05/2022
- Description:
- Grant (B1)
2
- Issue number:
- 202309
- Publication date:
- 01/03/2023
- Description:
- Opposition procedure started
3
- Issue number:
- 202342
- Publication date:
- 18/10/2023
- Description:
- Revocation of the European patent
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|